- Filed
- May 5, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 36.94M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 37.67M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $19.85M |
| Capex | Q1 2026 · Mar 31, 2026 | $1.54M |
| Capex | Q1 2026 · Mar 31, 2025 | $1.13M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $29.6M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $23.31M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $178.49M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $171.38M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $240.87M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $238.04M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $149.5M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $135.37M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $81.86M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $87.22M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $83.11M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $88.87M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $257.07M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $256.29M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $323.97M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $326.91M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.51 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.21 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.52 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.22 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $9.21M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $8.44M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $8.55M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $7.49M |
| Net Income | Q1 2026 · Mar 31, 2026 | $18.67M |
| Net Income | Q1 2026 · Mar 31, 2025 | $7.99M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $23.42M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $8M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $4.27M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $5.38M |
| Revenue | Q1 2026 · Mar 31, 2026 | $190.85M |
| Revenue | Q1 2026 · Mar 31, 2025 | $166.63M |